Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 511 entries
Sorted by: Best Match Show Resources per page
Nodular scabies: a classical case report in an adolescent boy.

Journal of parasitic diseases : official organ of the Indian Society for Parasitology

Ramachandra Reddy D, Ramachandra Reddy P.
PMID: 26345076
J Parasit Dis. 2015 Sep;39(3):581-3. doi: 10.1007/s12639-013-0365-7. Epub 2013 Nov 19.

This case report presents a classical case of nodular scabies in a 12 year boy who complained of itching for 20-21 days before presentation to the hospital. Application of Betnovate ointment (Betamethasone valerate 0.1 %) before presentation to the...

Cite
Ramachandra Reddy D, Ramachandra Reddy P. Nodular scabies: a classical case report in an adolescent boy. J Parasit Dis. 2013;39(3):581-3doi: 10.1007/s12639-013-0365-7.
Ramachandra Reddy, D., & Ramachandra Reddy, P. (2015). Nodular scabies: a classical case report in an adolescent boy. Journal of parasitic diseases : official organ of the Indian Society for Parasitology, 39(3), 581-3. https://doi.org/10.1007/s12639-013-0365-7
Ramachandra Reddy, Damodara, and Ramachandra Reddy, Prathap. "Nodular scabies: a classical case report in an adolescent boy." Journal of parasitic diseases : official organ of the Indian Society for Parasitology vol. 39,3 (2015): 581-3. doi: https://doi.org/10.1007/s12639-013-0365-7
Ramachandra Reddy D, Ramachandra Reddy P. Nodular scabies: a classical case report in an adolescent boy. J Parasit Dis. 2015 Sep;39(3):581-3. doi: 10.1007/s12639-013-0365-7. Epub 2013 Nov 19. PMID: 26345076; PMCID: PMC4554579.
Copy Download .nbib Format: NLM
In Vitro Toxicity of Local Anesthetics and Corticosteroids on Chondrocyte and Synoviocyte Viability and Metabolism.

Cartilage

Sherman SL, Khazai RS, James CH, Stoker AM, Flood DL, Cook JL.
PMID: 26425261
Cartilage. 2015 Oct;6(4):233-40. doi: 10.1177/1947603515594453.

OBJECTIVE: There is growing concern that intra-articular injection of local anesthetic and/or corticosteroids may cause significant morbidity, including potential toxicity to chondrocytes and synoviocytes, after even a single exposure. We demonstrate that full thickness canine chondral and synovial samples...

Cite
Sherman SL, Khazai RS, James CH, et al. In Vitro Toxicity of Local Anesthetics and Corticosteroids on Chondrocyte and Synoviocyte Viability and Metabolism. Cartilage. 2015;6(4):233-40doi: 10.1177/1947603515594453.
Sherman, S. L., Khazai, R. S., James, C. H., Stoker, A. M., Flood, D. L., & Cook, J. L. (2015). In Vitro Toxicity of Local Anesthetics and Corticosteroids on Chondrocyte and Synoviocyte Viability and Metabolism. Cartilage, 6(4), 233-40. https://doi.org/10.1177/1947603515594453
Sherman, Seth L, et al. "In Vitro Toxicity of Local Anesthetics and Corticosteroids on Chondrocyte and Synoviocyte Viability and Metabolism." Cartilage vol. 6,4 (2015): 233-40. doi: https://doi.org/10.1177/1947603515594453
Sherman SL, Khazai RS, James CH, Stoker AM, Flood DL, Cook JL. In Vitro Toxicity of Local Anesthetics and Corticosteroids on Chondrocyte and Synoviocyte Viability and Metabolism. Cartilage. 2015 Oct;6(4):233-40. doi: 10.1177/1947603515594453. PMID: 26425261; PMCID: PMC4568732.
Copy Download .nbib Format: NLM
Hypokalemic paraplegia in pregnancy.

Journal of clinical and diagnostic research : JCDR

Kulkarni M, Tv S, Gopal N.
PMID: 25121034
J Clin Diagn Res. 2014 Jun;8(6):OD03-4. doi: 10.7860/JCDR/2014/8793.4433. Epub 2014 Jun 20.

Hypokalemic myopathy may range from numbness/weakness to complete paralysis. The aetiology may be congenital or acquired. It is characterized by acute muscular weakness with low levels of potassium (

Cite
Kulkarni M, Tv S, Gopal N. Hypokalemic paraplegia in pregnancy. J Clin Diagn Res. 2014;8(6):OD03-4doi: 10.7860/JCDR/2014/8793.4433.
Kulkarni, M., Tv, S., & Gopal, N. (2014). Hypokalemic paraplegia in pregnancy. Journal of clinical and diagnostic research : JCDR, 8(6), OD03-4. https://doi.org/10.7860/JCDR/2014/8793.4433
Kulkarni, Maitri, et al. "Hypokalemic paraplegia in pregnancy." Journal of clinical and diagnostic research : JCDR vol. 8,6 (2014): OD03-4. doi: https://doi.org/10.7860/JCDR/2014/8793.4433
Kulkarni M, Tv S, Gopal N. Hypokalemic paraplegia in pregnancy. J Clin Diagn Res. 2014 Jun;8(6):OD03-4. doi: 10.7860/JCDR/2014/8793.4433. Epub 2014 Jun 20. PMID: 25121034; PMCID: PMC4129316.
Copy Download .nbib Format: NLM
Efficacy of intravitreal dexamethasone implant for prostaglandin-induced refractory pseudophakic cystoid macular edema: case report and review of the literature.

Clinical ophthalmology (Auckland, N.Z.)

Sacchi M, Villani E, Gilardoni F, Nucci P.
PMID: 25061272
Clin Ophthalmol. 2014 Jul 02;8:1253-7. doi: 10.2147/OPTH.S63829. eCollection 2014.

BACKGROUND: Macular edema is a known complication even after uneventful cataract surgery. The chronic use of prostaglandin analogs is a risk factor for the development of pseudophakic cystoid macular edema (CME). Nonsteroidal anti-inflammatory drugs (NSAIDs) are considered first-line therapy...

Cite
Sacchi M, Villani E, Gilardoni F, et al. Efficacy of intravitreal dexamethasone implant for prostaglandin-induced refractory pseudophakic cystoid macular edema: case report and review of the literature. Clin Ophthalmol. 2014;8:1253-7doi: 10.2147/OPTH.S63829.
Sacchi, M., Villani, E., Gilardoni, F., & Nucci, P. (2014). Efficacy of intravitreal dexamethasone implant for prostaglandin-induced refractory pseudophakic cystoid macular edema: case report and review of the literature. Clinical ophthalmology (Auckland, N.Z.), 81253-7. https://doi.org/10.2147/OPTH.S63829
Sacchi, Matteo, et al. "Efficacy of intravitreal dexamethasone implant for prostaglandin-induced refractory pseudophakic cystoid macular edema: case report and review of the literature." Clinical ophthalmology (Auckland, N.Z.) vol. 8 (2014): 1253-7. doi: https://doi.org/10.2147/OPTH.S63829
Sacchi M, Villani E, Gilardoni F, Nucci P. Efficacy of intravitreal dexamethasone implant for prostaglandin-induced refractory pseudophakic cystoid macular edema: case report and review of the literature. Clin Ophthalmol. 2014 Jul 02;8:1253-7. doi: 10.2147/OPTH.S63829. eCollection 2014. PMID: 25061272; PMCID: PMC4086850.
Copy Download .nbib Format: NLM
Novel spectrophotometric method for selective determination of compounds in ternary mixtures (dual wavelength in ratio spectra).

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy

Saad AS.
PMID: 25847787
Spectrochim Acta A Mol Biomol Spectrosc. 2015 Aug 05;147:257-61. doi: 10.1016/j.saa.2015.03.095. Epub 2015 Mar 31.

A simple selective spectrophotometric method for determination of compounds in ternary mixture was developed by combining the resolution power of two well-known methods that are commonly used for binary mixtures; namely ratio difference method and dual wavelength. The new...

Cite
Saad AS. Novel spectrophotometric method for selective determination of compounds in ternary mixtures (dual wavelength in ratio spectra). Spectrochim Acta A Mol Biomol Spectrosc. 2015;147:257-61doi: 10.1016/j.saa.2015.03.095.
Saad, A. S. (2015). Novel spectrophotometric method for selective determination of compounds in ternary mixtures (dual wavelength in ratio spectra). Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 147257-61. https://doi.org/10.1016/j.saa.2015.03.095
Saad, Ahmed S. "Novel spectrophotometric method for selective determination of compounds in ternary mixtures (dual wavelength in ratio spectra)." Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy vol. 147 (2015): 257-61. doi: https://doi.org/10.1016/j.saa.2015.03.095
Saad AS. Novel spectrophotometric method for selective determination of compounds in ternary mixtures (dual wavelength in ratio spectra). Spectrochim Acta A Mol Biomol Spectrosc. 2015 Aug 05;147:257-61. doi: 10.1016/j.saa.2015.03.095. Epub 2015 Mar 31. PMID: 25847787.
Copy Download .nbib Format: NLM
Metabolic and hormonal effects of antenatal betamethasone after 35 weeks of gestation.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG

Sifianou P, Thanou V, Karga H.
PMID: 25964731
J Pediatr Pharmacol Ther. 2015 Mar-Apr;20(2):138-43. doi: 10.5863/1551-6776-20.2.138.

BACKGROUND: Antenatal corticosteroid therapy recently has been considered for term and near-term infants, in addition to preterm infants, delivered by elective cesarean section, with the aim of preventing an adverse respiratory outcome.OBJECTIVES: The objective of this study was to...

Cite
Sifianou P, Thanou V, Karga H. Metabolic and hormonal effects of antenatal betamethasone after 35 weeks of gestation. J Pediatr Pharmacol Ther. 2015;20(2):138-43doi: 10.5863/1551-6776-20.2.138.
Sifianou, P., Thanou, V., & Karga, H. (2015). Metabolic and hormonal effects of antenatal betamethasone after 35 weeks of gestation. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 20(2), 138-43. https://doi.org/10.5863/1551-6776-20.2.138
Sifianou, Popi, et al. "Metabolic and hormonal effects of antenatal betamethasone after 35 weeks of gestation." The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG vol. 20,2 (2015): 138-43. doi: https://doi.org/10.5863/1551-6776-20.2.138
Sifianou P, Thanou V, Karga H. Metabolic and hormonal effects of antenatal betamethasone after 35 weeks of gestation. J Pediatr Pharmacol Ther. 2015 Mar-Apr;20(2):138-43. doi: 10.5863/1551-6776-20.2.138. PMID: 25964731; PMCID: PMC4418681.
Copy Download .nbib Format: NLM
Antenatal corticosteroids for women at risk of imminent preterm birth in low-resource countries: the case for equipoise and the need for efficacy trials.

BMJ global health

Vogel JP, Oladapo OT, Pileggi-Castro C, Adejuyigbe EA, Althabe F, Ariff S, Ayede AI, Baqui AH, Costello A, Chikamata DM, Crowther C, Fawole B, Gibbons L, Jobe AH, Kapasa ML, Kinuthia J, Kriplani A, Kuti O, Neilson J, Patterson J, Piaggio G, Qureshi R, Qureshi Z, Sankar MJ, Stringer JSA, Temmerman M, Yunis K, Bahl R, Metin Gülmezoglu A.
PMID: 29082019
BMJ Glob Health. 2017 Aug 30;2(3):e000398. doi: 10.1136/bmjgh-2017-000398. eCollection 2017.

The scientific basis for antenatal corticosteroids (ACS) for women at risk of preterm birth has rapidly changed in recent years. Two landmark trials-the Antenatal Corticosteroid Trial and the Antenatal Late Preterm Steroids Trial-have challenged the long-held assumptions on the...

Cite
Vogel JP, Oladapo OT, Pileggi-Castro C, et al. Antenatal corticosteroids for women at risk of imminent preterm birth in low-resource countries: the case for equipoise and the need for efficacy trials. BMJ Glob Health. 2017;2(3):e000398doi: 10.1136/bmjgh-2017-000398.
Vogel, J. P., Oladapo, O. T., Pileggi-Castro, C., Adejuyigbe, E. A., Althabe, F., Ariff, S., Ayede, A. I., Baqui, A. H., Costello, A., Chikamata, D. M., Crowther, C., Fawole, B., Gibbons, L., Jobe, A. H., Kapasa, M. L., Kinuthia, J., Kriplani, A., Kuti, O., Neilson, J., Patterson, J., Piaggio, G., Qureshi, R., Qureshi, Z., Sankar, M. J., Stringer, J. S. A., Temmerman, M., Yunis, K., Bahl, R., & Metin Gülmezoglu, A. (2017). Antenatal corticosteroids for women at risk of imminent preterm birth in low-resource countries: the case for equipoise and the need for efficacy trials. BMJ global health, 2(3), e000398. https://doi.org/10.1136/bmjgh-2017-000398
Vogel, Joshua P, et al. "Antenatal corticosteroids for women at risk of imminent preterm birth in low-resource countries: the case for equipoise and the need for efficacy trials." BMJ global health vol. 2,3 (2017): e000398. doi: https://doi.org/10.1136/bmjgh-2017-000398
Vogel JP, Oladapo OT, Pileggi-Castro C, Adejuyigbe EA, Althabe F, Ariff S, Ayede AI, Baqui AH, Costello A, Chikamata DM, Crowther C, Fawole B, Gibbons L, Jobe AH, Kapasa ML, Kinuthia J, Kriplani A, Kuti O, Neilson J, Patterson J, Piaggio G, Qureshi R, Qureshi Z, Sankar MJ, Stringer JSA, Temmerman M, Yunis K, Bahl R, Metin Gülmezoglu A. Antenatal corticosteroids for women at risk of imminent preterm birth in low-resource countries: the case for equipoise and the need for efficacy trials. BMJ Glob Health. 2017 Aug 30;2(3):e000398. doi: 10.1136/bmjgh-2017-000398. eCollection 2017. PMID: 29082019; PMCID: PMC5656119.
Copy Download .nbib Format: NLM
A Randomized Clinical Trial of Three Different Steroid Agents for Treatment of Low Backache through the Caudal Route.

Medical journal, Armed Forces India

Datta R, Upadhyay KK.
PMID: 27365757
Med J Armed Forces India. 2011 Jan;67(1):25-33. doi: 10.1016/S0377-1237(11)80007-9. Epub 2011 Jul 21.

BACKGROUND: Although epidural steroids are commonly used for conservative management of sciatica, controversies exist regarding optimal approach, type and dose of steroids, volume of injectate and frequency of administration. This randomized comparative blinded study was undertaken to compare the...

Cite
Datta R, Upadhyay KK. A Randomized Clinical Trial of Three Different Steroid Agents for Treatment of Low Backache through the Caudal Route. Med J Armed Forces India. 2011;67(1):25-33doi: 10.1016/S0377-1237(11)80007-9.
Datta, R., & Upadhyay, K. K. (2011). A Randomized Clinical Trial of Three Different Steroid Agents for Treatment of Low Backache through the Caudal Route. Medical journal, Armed Forces India, 67(1), 25-33. https://doi.org/10.1016/S0377-1237(11)80007-9
Datta, Rashmi, and Upadhyay, K K. "A Randomized Clinical Trial of Three Different Steroid Agents for Treatment of Low Backache through the Caudal Route." Medical journal, Armed Forces India vol. 67,1 (2011): 25-33. doi: https://doi.org/10.1016/S0377-1237(11)80007-9
Datta R, Upadhyay KK. A Randomized Clinical Trial of Three Different Steroid Agents for Treatment of Low Backache through the Caudal Route. Med J Armed Forces India. 2011 Jan;67(1):25-33. doi: 10.1016/S0377-1237(11)80007-9. Epub 2011 Jul 21. PMID: 27365757; PMCID: PMC4920614.
Copy Download .nbib Format: NLM
Comparative evaluation of low-level laser and systemic steroid therapy in adjuvant-enhanced arthritis of rat temporomandibular joint: A histological study.

Dental research journal

Khozeimeh F, Moghareabed A, Allameh M, Baradaran S.
PMID: 26005460
Dent Res J (Isfahan). 2015 May-Jun;12(3):215-23.

BACKGROUND: Low-level laser therapy (LLLT) has shown a promising effect in ameliorating symptoms of rheumatoid arthritis (RA). The aim of this investigation was to compare the early and late anti-inflammatory effects of LLLT and betamethasone in RA.MATERIALS AND METHODS:...

Cite
Khozeimeh F, Moghareabed A, Allameh M, et al. Comparative evaluation of low-level laser and systemic steroid therapy in adjuvant-enhanced arthritis of rat temporomandibular joint: A histological study. Dent Res J (Isfahan). 2015;12(3):215-23
Khozeimeh, F., Moghareabed, A., Allameh, M., & Baradaran, S. (2015). Comparative evaluation of low-level laser and systemic steroid therapy in adjuvant-enhanced arthritis of rat temporomandibular joint: A histological study. Dental research journal, 12(3), 215-23.
Khozeimeh, Faezeh, et al. "Comparative evaluation of low-level laser and systemic steroid therapy in adjuvant-enhanced arthritis of rat temporomandibular joint: A histological study." Dental research journal vol. 12,3 (2015): 215-23.
Khozeimeh F, Moghareabed A, Allameh M, Baradaran S. Comparative evaluation of low-level laser and systemic steroid therapy in adjuvant-enhanced arthritis of rat temporomandibular joint: A histological study. Dent Res J (Isfahan). 2015 May-Jun;12(3):215-23. PMID: 26005460; PMCID: PMC4432603.
Copy Download .nbib Format: NLM
Modulation of oxazolone-induced hypersensitivity in mice by selective PDE inhibitors.

Mediators of inflammation

Moodley I, Sotsios Y, Bertin B.
PMID: 18475626
Mediators Inflamm. 1995;4(2):112-6. doi: 10.1155/S0962935195000196.

The effects of PDE inhibitors on oxazolone-induced contact hypersensitivity (CS) were studied in mice. Rolipram, Ro 20-1724 and theophylline dose dependently inhibited CS but none caused >53% inhibition. ED(30) values at 24 h before challenge for rolipram, Ro 20-1724...

Cite
Moodley I, Sotsios Y, Bertin B. Modulation of oxazolone-induced hypersensitivity in mice by selective PDE inhibitors. Mediators Inflamm. 1995;4(2):112-6doi: 10.1155/S0962935195000196.
Moodley, I., Sotsios, Y., & Bertin, B. (1995). Modulation of oxazolone-induced hypersensitivity in mice by selective PDE inhibitors. Mediators of inflammation, 4(2), 112-6. https://doi.org/10.1155/S0962935195000196
Moodley, I, et al. "Modulation of oxazolone-induced hypersensitivity in mice by selective PDE inhibitors." Mediators of inflammation vol. 4,2 (1995): 112-6. doi: https://doi.org/10.1155/S0962935195000196
Moodley I, Sotsios Y, Bertin B. Modulation of oxazolone-induced hypersensitivity in mice by selective PDE inhibitors. Mediators Inflamm. 1995;4(2):112-6. doi: 10.1155/S0962935195000196. PMID: 18475626; PMCID: PMC2365615.
Copy Download .nbib Format: NLM
Topical treatment for phimosis: time span and other factors behind treatment effectiveness.

Journal of pediatric urology

Garcia de Freitas R, Nobre YD, Demarchi GT, Hachul M, Macedo A, Srougi M, Ortiz V.
PMID: 18947640
J Pediatr Urol. 2006 Aug;2(4):380-5. doi: 10.1016/j.jpurol.2006.05.006. Epub 2006 Jun 27.

OBJECTIVE: To study the factors that may influence the effectiveness of 0.2% betamethasone/hyaluronidase cream in the treatment of phimosis.METHODS: We treated 427 patients (3-10 years old, mean 6.33) in a prospective, randomized, blind study, with 214 patients on a...

Cite
Garcia de Freitas R, Nobre YD, Demarchi GT, et al. Topical treatment for phimosis: time span and other factors behind treatment effectiveness. J Pediatr Urol. 2006;2(4):380-5doi: 10.1016/j.jpurol.2006.05.006.
Garcia de Freitas, R., Nobre, Y. D., Demarchi, G. T., Hachul, M., Macedo, A., Srougi, M., & Ortiz, V. (2006). Topical treatment for phimosis: time span and other factors behind treatment effectiveness. Journal of pediatric urology, 2(4), 380-5. https://doi.org/10.1016/j.jpurol.2006.05.006
Garcia de Freitas, Ricardo, et al. "Topical treatment for phimosis: time span and other factors behind treatment effectiveness." Journal of pediatric urology vol. 2,4 (2006): 380-5. doi: https://doi.org/10.1016/j.jpurol.2006.05.006
Garcia de Freitas R, Nobre YD, Demarchi GT, Hachul M, Macedo A, Srougi M, Ortiz V. Topical treatment for phimosis: time span and other factors behind treatment effectiveness. J Pediatr Urol. 2006 Aug;2(4):380-5. doi: 10.1016/j.jpurol.2006.05.006. Epub 2006 Jun 27. PMID: 18947640.
Copy Download .nbib Format: NLM
Qualitative and quantitative assessment of the benefit-risk ratio of medium potency topical corticosteroids in vitro and in vivo: characterisation of drugs with an increased benefit-risk ratio.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Schackert C, Korting HC, Schäfer-Korting M.
PMID: 18034533
BioDrugs. 2000 Apr;13(4):267-77. doi: 10.2165/00063030-200013040-00005.

Corticosteroids are widely used for the treatment of inflammatory skin disorders. However, systemic and local adverse drug reactions, especially skin atrophy, are potential complications that limit their use. Several attempts have been made to increase the safety of topical...

Cite
Schackert C, Korting HC, Schäfer-Korting M. Qualitative and quantitative assessment of the benefit-risk ratio of medium potency topical corticosteroids in vitro and in vivo: characterisation of drugs with an increased benefit-risk ratio. BioDrugs. 2000;13(4):267-77doi: 10.2165/00063030-200013040-00005.
Schackert, C., Korting, H. C., & Schäfer-Korting, M. (2000). Qualitative and quantitative assessment of the benefit-risk ratio of medium potency topical corticosteroids in vitro and in vivo: characterisation of drugs with an increased benefit-risk ratio. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 13(4), 267-77. https://doi.org/10.2165/00063030-200013040-00005
Schackert, C, et al. "Qualitative and quantitative assessment of the benefit-risk ratio of medium potency topical corticosteroids in vitro and in vivo: characterisation of drugs with an increased benefit-risk ratio." BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy vol. 13,4 (2000): 267-77. doi: https://doi.org/10.2165/00063030-200013040-00005
Schackert C, Korting HC, Schäfer-Korting M. Qualitative and quantitative assessment of the benefit-risk ratio of medium potency topical corticosteroids in vitro and in vivo: characterisation of drugs with an increased benefit-risk ratio. BioDrugs. 2000 Apr;13(4):267-77. doi: 10.2165/00063030-200013040-00005. PMID: 18034533.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 511 entries